| 8.93 BATS BZX Real-Time Price As of 3:00pm ET |  +0.09 / +1.02%Today’s Change | 6.75 Today|||52-Week Range 16.76 | -21.60% Year-to-Date |
| Intra-Cellular Therapies Inc (ITCI) Q3 2019 Earnings Call Transcript Nov 05 / MotleyFool.com - Paid Partner Content |
| Previous close | 8.84 |
| Today’s open | 8.89 |
| Day’s range | 8.79 - 9.00 |
| Volume | 152,226 |
| Average volume (3 months) | 999,419 |
| Market cap | $529.4M |
| Earnings growth (last year) | -33.75% |
| Earnings growth (this year) | +2.86% |
| Earnings growth (next 5 years) | +2.50% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.66 |
| Today’s change | Today’s % change | |
|---|---|---|
| CPRXCatalyst Pharmaceuti... | -0.31 | -6.60% |
| CYTKCytokinetics Inc | +0.13 | +1.66% |
| STMLStemline Therapeutic... | +0.40 | +4.22% |
| PGNXProgenics Pharmaceut... | -0.11 | -1.88% |
| Next reporting date | February 25, 2020 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$155.1M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
